QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Transdermal Patch market in its latest report. All of the market forecasts presented in the report are authentic and reliable.
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patch es include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others. Transdermal Patch es are mainly classified into the following types: Methyl Salicylate-based Patches, Rivastigmine Patches, Fentanyl Patches, Lidocaine Patches, Diclofenac Patches, Nicotine Patches and others.
Methyl Salicylate-based segment accounted for the larger part of the revenue market, with 18%, followed by Lidocaine Patches, with 15%. Transdermal Patch es can delivery drugs through Rx Channel or OTC Channel. The former took a larger market share, with its sales volume accounting for about 76% of the total. Hisamitsu Pharmaceutical, Johnson & Johnson, Nitto Denko and Mylan are the Top 4 players of the global Transdermal Patch market. They took up about 42% of the global market in 2019. Market Analysis and Insights: Global Transdermal Patch Market The global Transdermal Patch market size is projected to reach US$ 8379.4 million by 2027, from US$ 6429 million in 2020, at a CAGR of 3.6% during 2021-2027.
Request Sample Report and Full Report TOC:
https://www.qyresearch.com/sample-form/form/3269680/global-transdermal-patch-market
The Essential Content Covered in the Global Transdermal Patch Market Report :
* Top Key Company Profiles.
* Main Business and Rival Information
* SWOT Analysis and PESTEL Analysis
* Production, Sales, Revenue, Price and Gross Margin
* Market Share and Size
Top Players of Transdermal Patch Market are Studied: Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Grünenthal, IBSA Group, GSK, Luye Pharma Group, Pfizer, Chattem, Dr Reddy’s Laboratories, Bayer, Mundipharma, Endo International, Beijing Tide Pharmaceutical
The report provides a 6-year forecast (2021-2027) assessed based on how the Transdermal Patch market is predicted to grow in major regions like USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.
Segmentation by Type: Methyl Salicylate-based Patch, Rivastigmine Transdermal Patch, Fentanyl Transdermal Patch, Lidocaine Patch, Diclofenac Patch, Nicotine Transdermal Patch, Others
Segmentation by Application: Rx Channel, OTC Channel
- Get Full Customize report or for any Special Discount visit@
- https://www.qyresearch.com/customize-request/form/3269680/global-transdermal-patch-market
Reasons to Buy this Report:
- Industry Size & Forecast: Estimations on the global Transdermal Patch industry size on the basis of value and volume are provided in this part of the report
- Study on Key Industry Trends: This section offers deep insights into the prevailing and upcoming Transdermal Patch trends
- Segmental Analysis: Here, the report has examined the high-growth segments including product type, application, and end-users, taking into account their CAGR, share, and size
- Future Prospects: Current Transdermal Patch developments and future opportunities estimated to emerge in the Transdermal Patch industry are looked into in this portion of the study
- Geography-wise Analysis: The authors of the report have studied the regions having growth potential to help companies plan their future investments
- Study on Competitive Landscape: The industry experts have offered thorough information about the strategic tactics adopted by the industry participants to consolidate their position. This assessment will help the players to strategize their activities in future.
TOC
1 Transdermal Patch Market Overview
1.1 Transdermal Patch Product Overview
1.2 Transdermal Patch Market Segment by Type
1.2.1 Methyl Salicylate-based Patch
1.2.2 Rivastigmine Transdermal Patch
1.2.3 Fentanyl Transdermal Patch
1.2.4 Lidocaine Patch
1.2.5 Diclofenac Patch
1.2.6 Nicotine Transdermal Patch
1.2.7 Others
1.3 Global Transdermal Patch Market Size by Type
1.3.1 Global Transdermal Patch Market Size Overview by Type (2016-2027)
1.3.2 Global Transdermal Patch Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Transdermal Patch Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Transdermal Patch Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Transdermal Patch Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Transdermal Patch Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Transdermal Patch Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Transdermal Patch Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Transdermal Patch Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Patch Sales Breakdown by Type (2016-2021)
1.4.2 Europe Transdermal Patch Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Transdermal Patch Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Transdermal Patch Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Transdermal Patch Sales Breakdown by Type (2016-2021) 2 Global Transdermal Patch Market Competition by Company
2.1 Global Top Players by Transdermal Patch Sales (2016-2021)
2.2 Global Top Players by Transdermal Patch Revenue (2016-2021)
2.3 Global Top Players Transdermal Patch Price (2016-2021)
2.4 Global Top Manufacturers Transdermal Patch Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Patch Market Competitive Situation and Trends
2.5.1 Transdermal Patch Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Patch Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Patch as of 2020)
2.7 Date of Key Manufacturers Enter into Transdermal Patch Market
2.8 Key Manufacturers Transdermal Patch Product Offered
2.9 Mergers & Acquisitions, Expansion 3 Transdermal Patch Status and Outlook by Region
3.1 Global Transdermal Patch Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Transdermal Patch Historic Market Size by Region
3.2.1 Global Transdermal Patch Sales in Volume by Region (2016-2021)
3.2.2 Global Transdermal Patch Sales in Value by Region (2016-2021)
3.2.3 Global Transdermal Patch Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Transdermal Patch Forecasted Market Size by Region
3.3.1 Global Transdermal Patch Sales in Volume by Region (2022-2027)
3.3.2 Global Transdermal Patch Sales in Value by Region (2022-2027)
3.3.3 Global Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Transdermal Patch by Application
4.1 Transdermal Patch Market Segment by Application
4.1.1 Rx Channel
4.1.2 OTC Channel
4.2 Global Transdermal Patch Market Size by Application
4.2.1 Global Transdermal Patch Market Size Overview by Application (2016-2027)
4.2.2 Global Transdermal Patch Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Transdermal Patch Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Transdermal Patch Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Transdermal Patch Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Transdermal Patch Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Transdermal Patch Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Transdermal Patch Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Transdermal Patch Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Patch Sales Breakdown by Application (2016-2021)
4.3.2 Europe Transdermal Patch Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Transdermal Patch Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Transdermal Patch Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Transdermal Patch Sales Breakdown by Application (2016-2021) 5 North America Transdermal Patch by Country
5.1 North America Transdermal Patch Historic Market Size by Country
5.1.1 North America Transdermal Patch Sales in Volume by Country (2016-2021)
5.1.2 North America Transdermal Patch Sales in Value by Country (2016-2021)
5.2 North America Transdermal Patch Forecasted Market Size by Country
5.2.1 North America Transdermal Patch Sales in Volume by Country (2022-2027)
5.2.2 North America Transdermal Patch Sales in Value by Country (2022-2027) 6 Europe Transdermal Patch by Country
6.1 Europe Transdermal Patch Historic Market Size by Country
6.1.1 Europe Transdermal Patch Sales in Volume by Country (2016-2021)
6.1.2 Europe Transdermal Patch Sales in Value by Country (2016-2021)
6.2 Europe Transdermal Patch Forecasted Market Size by Country
6.2.1 Europe Transdermal Patch Sales in Volume by Country (2022-2027)
6.2.2 Europe Transdermal Patch Sales in Value by Country (2022-2027) 7 Asia-Pacific Transdermal Patch by Region
7.1 Asia-Pacific Transdermal Patch Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Patch Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Transdermal Patch Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Transdermal Patch Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Patch Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Transdermal Patch Sales in Value by Region (2022-2027) 8 Latin America Transdermal Patch by Country
8.1 Latin America Transdermal Patch Historic Market Size by Country
8.1.1 Latin America Transdermal Patch Sales in Volume by Country (2016-2021)
8.1.2 Latin America Transdermal Patch Sales in Value by Country (2016-2021)
8.2 Latin America Transdermal Patch Forecasted Market Size by Country
8.2.1 Latin America Transdermal Patch Sales in Volume by Country (2022-2027)
8.2.2 Latin America Transdermal Patch Sales in Value by Country (2022-2027) 9 Middle East and Africa Transdermal Patch by Country
9.1 Middle East and Africa Transdermal Patch Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Patch Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Transdermal Patch Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Transdermal Patch Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Patch Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Transdermal Patch Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Transdermal Patch Business
10.1 Hisamitsu Pharmaceutical
10.1.1 Hisamitsu Pharmaceutical Corporation Information
10.1.2 Hisamitsu Pharmaceutical Introduction and Business Overview
10.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Hisamitsu Pharmaceutical Transdermal Patch Products Offered
10.1.5 Hisamitsu Pharmaceutical Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Corporation Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Johnson & Johnson Transdermal Patch Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Novartis
10.3.1 Novartis Corporation Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Novartis Transdermal Patch Products Offered
10.3.5 Novartis Recent Development
10.4 UCB Pharma
10.4.1 UCB Pharma Corporation Information
10.4.2 UCB Pharma Introduction and Business Overview
10.4.3 UCB Pharma Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.4.4 UCB Pharma Transdermal Patch Products Offered
10.4.5 UCB Pharma Recent Development
10.5 Mylan
10.5.1 Mylan Corporation Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Mylan Transdermal Patch Products Offered
10.5.5 Mylan Recent Development
10.6 Teva Pharmaceutical
10.6.1 Teva Pharmaceutical Corporation Information
10.6.2 Teva Pharmaceutical Introduction and Business Overview
10.6.3 Teva Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Teva Pharmaceutical Transdermal Patch Products Offered
10.6.5 Teva Pharmaceutical Recent Development
10.7 Nitto Denko
10.7.1 Nitto Denko Corporation Information
10.7.2 Nitto Denko Introduction and Business Overview
10.7.3 Nitto Denko Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Nitto Denko Transdermal Patch Products Offered
10.7.5 Nitto Denko Recent Development
10.8 Grünenthal
10.8.1 Grünenthal Corporation Information
10.8.2 Grünenthal Introduction and Business Overview
10.8.3 Grünenthal Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Grünenthal Transdermal Patch Products Offered
10.8.5 Grünenthal Recent Development
10.9 IBSA Group
10.9.1 IBSA Group Corporation Information
10.9.2 IBSA Group Introduction and Business Overview
10.9.3 IBSA Group Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.9.4 IBSA Group Transdermal Patch Products Offered
10.9.5 IBSA Group Recent Development
10.10 GSK
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Transdermal Patch Product Category, Application and Specification
10.10.3 GSK Transdermal Patch Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 GSK Recent Development
10.11 Luye Pharma Group
10.11.1 Luye Pharma Group Corporation Information
10.11.2 Luye Pharma Group Introduction and Business Overview
10.11.3 Luye Pharma Group Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Luye Pharma Group Transdermal Patch Products Offered
10.11.5 Luye Pharma Group Recent Development
10.12 Pfizer
10.12.1 Pfizer Corporation Information
10.12.2 Pfizer Introduction and Business Overview
10.12.3 Pfizer Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Pfizer Transdermal Patch Products Offered
10.12.5 Pfizer Recent Development
10.13 Chattem
10.13.1 Chattem Corporation Information
10.13.2 Chattem Introduction and Business Overview
10.13.3 Chattem Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Chattem Transdermal Patch Products Offered
10.13.5 Chattem Recent Development
10.14 Dr Reddy’s Laboratories
10.14.1 Dr Reddy’s Laboratories Corporation Information
10.14.2 Dr Reddy’s Laboratories Introduction and Business Overview
10.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Dr Reddy’s Laboratories Transdermal Patch Products Offered
10.14.5 Dr Reddy’s Laboratories Recent Development
10.15 Bayer
10.15.1 Bayer Corporation Information
10.15.2 Bayer Introduction and Business Overview
10.15.3 Bayer Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Bayer Transdermal Patch Products Offered
10.15.5 Bayer Recent Development
10.16 Mundipharma
10.16.1 Mundipharma Corporation Information
10.16.2 Mundipharma Introduction and Business Overview
10.16.3 Mundipharma Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Mundipharma Transdermal Patch Products Offered
10.16.5 Mundipharma Recent Development
10.17 Endo International
10.17.1 Endo International Corporation Information
10.17.2 Endo International Introduction and Business Overview
10.17.3 Endo International Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Endo International Transdermal Patch Products Offered
10.17.5 Endo International Recent Development
10.18 Beijing Tide Pharmaceutical
10.18.1 Beijing Tide Pharmaceutical Corporation Information
10.18.2 Beijing Tide Pharmaceutical Introduction and Business Overview
10.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Beijing Tide Pharmaceutical Transdermal Patch Products Offered
10.18.5 Beijing Tide Pharmaceutical Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Patch Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Patch Industrial Chain Analysis
11.4 Transdermal Patch Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Patch Distributors
12.3 Transdermal Patch Downstream Customers 13 Research Findings and Conclusion 14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
About Us
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.